ClinicalTrials.Veeva

Menu

Comparison of Misoprostol and Prostaglandin E2 (PGE2) Gel for Induction of Labour in Premature Rupture of Membranes at Term

N

Nilratan Sircar Medical College

Status and phase

Completed
Phase 4

Conditions

Premature Rupture of Membranes at Term

Treatments

Drug: Misoprostol
Drug: PGE2 gel

Study type

Interventional

Funder types

Other

Identifiers

NCT00355303
2-Chaudhuri

Details and patient eligibility

About

The purpose of this study is to determine whether induction of labor with vaginal misoprostol application will result in fewer cesarean deliveries than vaginal PGE2 gel application in women with premature rupture of membranes at term.

Enrollment

932 patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Premature rupture of membranes at 37 or more weeks
  • Single live fetus in cephalic presentation

Exclusion criteria

  • Women in labour
  • Women with contraindication of induction of labour
  • Women with previous caesarean section or uterine surgery

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

932 participants in 1 patient group

Misoprostol tablet, PGE2 gel
Active Comparator group
Description:
participants are assigned to one of two arms for the duration of the study In one group induction of labour is done by intravaginal misoprostol tablets at 4 hrly interval with maximum of five doses.In other group PGE2 gel is applied in poaterior fornix at six hourly interval.
Treatment:
Drug: PGE2 gel
Drug: Misoprostol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems